Showing BioInteractions for Catumaxomab (DB06607)
BioInteractor utilizes data on drug-target, -enzyme and -transporter associations to provide insight on drug-drug interactions. It allows you to identify, for instance, which drugs act similarly on the same target. Such drugs may have additive pharmacodynamic effects if given concomitantly. Conversely, two drugs may antagonize the beneficial effects of each other by having opposite actions on a specific drug target. BioInteractor uses ranked drug-enzyme association information to predict enzyme-mediated drug interactions that may be clinically relevant.
| Interacting Group | Interacting Drugs | |
|---|---|---|
| Catumaxomab is a Epithelial cell adhesion molecule ligand | ||
| 1 | Epithelial cell adhesion molecule binders | Technetium Tc-99m nofetumomab merpentan |
| Interacting Group | Interacting Drugs | |
|---|---|---|
| Catumaxomab is a Low affinity immunoglobulin gamma Fc region receptor II-a agonist | ||
| 1 | Low affinity immunoglobulin gamma Fc region receptor II-a binders | Cetuximab |
| 2 | Low affinity immunoglobulin gamma Fc region receptor II-a ligands | Etanercept |
| 3 | Low affinity immunoglobulin gamma Fc region receptor II-a antagonists | Human immunoglobulin G |
| Interacting Group | Interacting Drugs | |
|---|---|---|
| Catumaxomab is a Low affinity immunoglobulin gamma Fc region receptor III-A agonist | ||
| 1 | Low affinity immunoglobulin gamma Fc region receptor III-A binders | Cetuximab |
| 2 | Low affinity immunoglobulin gamma Fc region receptor III-A ligands | Etanercept |
| 3 | Low affinity immunoglobulin gamma Fc region receptor III-A antagonists | Human immunoglobulin G |
| 4 | Low affinity immunoglobulin gamma Fc region receptor III-A bindings | Benralizumab |
| Interacting Group | Interacting Drugs | |
|---|---|---|
| Catumaxomab is a Low affinity immunoglobulin gamma Fc region receptor III-B agonist | ||
| 1 | Low affinity immunoglobulin gamma Fc region receptor III-B binders | Cetuximab |
| 2 | Low affinity immunoglobulin gamma Fc region receptor III-B ligands | Etanercept |
| 3 | Low affinity immunoglobulin gamma Fc region receptor III-B antagonists | Human immunoglobulin G |
| Interacting Group | Interacting Drugs | |
|---|---|---|
| Catumaxomab is a T-cell surface glycoprotein CD3 epsilon chain agonist | ||
| 1 | T-cell surface glycoprotein CD3 epsilon chain binders | Muromonab |
| Interacting Group | Interacting Drugs | |
|---|---|---|
| Catumaxomab is a High affinity immunoglobulin gamma Fc receptor I agonist | ||
| 1 | High affinity immunoglobulin gamma Fc receptor I antagonists | Human immunoglobulin G, Porfimer sodium |
| 2 | High affinity immunoglobulin gamma Fc receptor I binders | Atomoxetine, Cetuximab |
| 3 | High affinity immunoglobulin gamma Fc receptor I ligands | Etanercept |